Description

This funding opportunity from the National Cancer Institute (NCI) aims to accelerate the translation of scientific discoveries and engineering developments in imaging, data science, and spectroscopic technologies into practical tools or methods that address key challenges in cancer biology, risk assessment, diagnosis, treatment, and disease monitoring. The program specifically requires the formation of academic-industrial partnerships, fostering collaboration between academic and industrial investigators to drive translational research in imaging beyond what either sector could achieve alone.

Projects should focus on advancing technologies that are ready for optimization and validation, with the goal of delivering new capabilities to end users in clinical, pre-clinical, or non-clinical cancer research settings. The program supports clinical trials that test or validate the performance of these technologies but does not fund commercial production, basic research, or clinical studies lacking a translational focus.